GlassScriptPhysician profile
Kin Wai Hung
NPI 1700129541
$7,293.92
in general payments reported to CMS, 2019-2025
7 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $122 · 2020: $15.53 · 2023: $14.10 · 2024: $7,142.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,080 · Travel and Lodging: $62.19 · Food and Beverage: $14.10.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,080.00 |
| Travel and Lodging | $62.19 |
| Food and Beverage | $14.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Pharmaceuticals, INC. | $7,142.19 | 2024 | Libtayo |
| E.R. Squibb & Sons, L.L.C. | $43.84 | 2019 | |
| Janssen Pharmaceuticals, INC | $39.64 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.57 | 2019 | |
| Alexion Pharmaceuticals, INC. | $19.05 | 2019 | |
| Pfizer INC. | $15.53 | 2020 | |
| Hollister Incorporated | $14.10 | 2023 | Vapro Plus Pocket |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kin Wai Hung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.